About Fulzerasib Fulzerasib is a novel, orally active, potent KRAS G12C inhibitor designed to effectively target the…
About Ensartinib Ensartinib is a novel, aminopyridazine-based small molecule that potently inhibits ALK. Ensartinib is 10-fold…
About Penpulimab Penpulimab is an IgG1 monoclonal antibody that's designed to eliminate Fcγ receptor binding and…
Sunvozertinib (DZD9008) is an oral, potent, irreversible, and selective EGFR TKI targeting EGFR exon20ins as well as EGFR sensitizing,…
About Ivonescimab Ivonescimab is the most advanced PD-1/VEGF bispecific antibody in clinical development in the U.S.,…
About Glumetinib or Gumarontinib Glumetinib (SCC244) also named Gumarontinib， is a highly selective, orally bioavailable, ATP-competitive c-Met…
About Vebreltinib Vebreltinib (also known as bozitinib) is a pharmaceutical drug used for the treatment of…
INDICATIONS AND USAGE Afatinib is a kinase inhibitor indicated for: • First-line treatment of patients with…
INDICATIONS AND USAGE Erlotinib is a kinase inhibitor indicated for: · The treatment of patients with metastatic…
INDICATIONS AND USAGE Dacomitinib is a kinase inhibitor indicated for the first-line treatment of patients with…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Aumolertinib Aumolertinib (previously known as almonertinib) is a EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Toripalimab Toripalimab-tpzi is a next generation anti-PD-1 monoclonal antibody that blocks PD-L1 binding to the…
Copyright © 2021-2022 LienTeh.net All rights reserved.
